Akers Biosciences, Inc. Human Resources Contracts & Agreements
35 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Consulting Agreements (3)
- Employment Agreements (21)
- Separation Agreements (1)
- Severance Agreements (1)
- First Amendment to the TNF Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 26, 2024)
- General Release and Severance Agreement, by and between MyMD Pharmaceuticals, Inc. and Christopher Chapman, dated as of June 14, 2024 (Filed With SEC on June 17, 2024)
- Seventh Amendment to Employment Agreement, dated September 6, 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Chris Chapman (Filed With SEC on April 1, 2024)
- Employment Mutual Separation Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Paul M. Rivard (Filed With SEC on November 14, 2023)
- Fourth Amendment to Employment Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Adam Kaplin (Filed With SEC on November 14, 2023)
- Eighth Amendment to Employment Agreement, dated November 13 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Chris Chapman (Filed With SEC on November 14, 2023)
- Third Amendment to Employment Agreement between Paul Rivard, Esq. and MyMD Pharmaceuticals, Inc., dated March 22, 2023 (Filed With SEC on March 23, 2023)
- Sixth Amendment to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated January 1, 2023 (Filed With SEC on February 3, 2023)
- Third Amendment to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals, Inc., dated August 30, 2022 (Filed With SEC on November 10, 2022)
- Fifth Amendment to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated August 30, 2022 (Filed With SEC on November 10, 2022)
- Amendment No. 2 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals, Inc., dated November 24, 2021 (Filed With SEC on March 31, 2022)
- Amendment No. 4 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated November 24, 2021 (Filed With SEC on March 31, 2022)
- Amendment No. 2 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)
- Amendment No. 1 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated November 24, 2020 (Filed With SEC on May 18, 2021)
- Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated September 21, 2020 (Filed With SEC on May 18, 2021)
- Amendment No. 3 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated February 11, 2021 (Filed With SEC on May 18, 2021)
- Amendment No. 2 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated January 8, 2021 (Filed With SEC on May 18, 2021)
- Amendment No. 1 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020 (Filed With SEC on May 18, 2021)
- Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., effective November 1, 2020 (Filed With SEC on May 18, 2021)
- Amendment No. 1 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc, dated February 11, 2021 (Filed With SEC on May 18, 2021)
- Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc., effective December 18, 2020 (Filed With SEC on May 18, 2021)
- MyMD Pharmaceuticals (Florida) Inc. Second Amendment to Amended and Restated 2016 Stock Incentive Plan, dated July 1, 2019 (Filed With SEC on May 18, 2021)
- Form of Incentive Stock Option Agreement (Filed With SEC on April 22, 2021)
- MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 22, 2021)
- CFO Consulting Agreement, dated as of July 21, 2020, between Akers Biosciences, Inc. and Brio Financial Group (Filed With SEC on July 22, 2020)
- Offer of Employment, dated January 6, 2020 (Filed With SEC on January 6, 2020)
- Form of Akers Biosciences, Inc. 2018 Equity Incentive Plan (Filed With SEC on December 7, 2018)
- Offer of Employment, dated October 5, 2018 (Filed With SEC on October 12, 2018)
- Offer of Employment, dated October 5, 2018 (Filed With SEC on October 11, 2018)
- AKERSBIOSCIENCES, INC. 2017EQUITY INCENTIVE PLAN (Filed With SEC on August 11, 2017)
- FIRSTAMENDMENT TO AKERSBIOSCIENCES, INC. AMENDED AND RESTATED 2013 INCENTIVE STOCK AND AWARDPLAN (Filed With SEC on October 12, 2016)
- AKERS BIOSCIENCES, INC. FIRST AMENDED AND RESTATED 2013 INCENTIVE STOCK AND AWARD PLAN (Filed With SEC on January 9, 2015)
- AKERS BIOSCIENCES, INC. 2013 INCENTIVE STOCK AND AWARD PLAN (Filed With SEC on December 6, 2013)
- CONSULTING SERVICES AGREEMENT (Filed With SEC on August 7, 2013)
- CONSULTING SERVICES AGREEMENT (Filed With SEC on August 7, 2013)
